相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
B7-H1 / CD274 / PD-L1抗体
抗体类型: Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform )
克隆号 : 1
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : This antibody was obtained from a rabbit immunized with purified, human cell-derived, recombinant human B7-H1 ( rh B7-H1; Catalog#10084-H08H ; NP_054862.1 ; Met 1 - Thr 239 )
B7-H1 / CD274 / PD-L1抗体背景综述
Human B7 homolog 1 (B7-H1), also called programmed death ligand 1 (PD-L1), is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses. B7-H1 is a cell surface immunoglobulin superfamily with two Ig-like domains within the extracellular region and a short cytoplasmic domain. This protein is broadly expressed in the majority of peripheral tissues as well as hematopoietic cells. Interaction between B7-H1 and its receptors belonging to the CD28 family of molecules provide both stimulatory and inhibitory signals in regulating T cell activation and tolerance. As a costimulator, B7-H1 induces T-cell proliferation and preferentially the production of interleukin 10 and interferon gamma. Conversely, by binding to programmed death 1 receptors (PD-1) on activated T-cells and B-cells, B7-H1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, B7-H1 leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. B7-H1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
B7-H1 / CD274 / PD-L1抗体相关产品如下:xy-3442R Phospho-Tuberin(Ser939)磷酸化马铃薯球蛋白(结节性硬化)抗体
xy-3443R Phospho-Tuberin(Tyr1571)磷酸化马铃薯球蛋白(结节性硬化)抗体
xy-3444R Phospho-TSC2 (Thr1462)磷酸化马铃薯球蛋白(结节性硬化)抗体
xy-3445R Phospho-Tuberin (Thr927)磷酸化马铃薯球蛋白(结节性硬化)抗体
xy-3446R phospho-Tau protein(Ser396)磷酸化微管相关蛋白抗体
xy-3587R TNK1非受体型酪氨酸蛋白激酶Tnk1抗体
xy-3450R Phospho-TNK1 (Tyr277)磷酸化非受体型酪氨酸蛋白激酶Tnk1抗体
xy-3451R phospho-TOPO II Alpha (Ser1106)磷酸化DNA拓普西异构酶Ⅱ抗体
xy-3588R TORC1环腺苷酸应答元件结合蛋白转录共激活因子TORC1抗体
xy-3453R Phospho-Torc1 (Ser151)磷酸化CREB转录共激活因子TORC1抗体
xy-3590R TORC2CREB转录共激活因子TORC2抗体
xy-0093R TNF beta肿瘤坏死因子β抗体(TNFβ)
xy-1280R TCF7L2转录因子7类似物2抗体
xy-0507R TBX2血栓素B2(一种新发现的抑癌基因)抗体
xy-9734R TSSK6睾丸特异丝氨酸/苏氨酸激酶6抗体
xy-9735R TSEN2tRNA剪接内切酶2抗体
xy-9736R D53肿瘤蛋白D53抗体
xy-7676R TRAF7肿瘤坏死因子受体相关因子7抗体
xy-6851R TPST2酪蛋白硫酸转移酶2抗体
xy-7111R EDA2R肿瘤坏死因子受体超家族成员27抗体
xy-9422R TSPAN14四分子交联体14抗体(四旋蛋白)
xy-13806R TAP26/CCDC59甲状腺转录因子1相关蛋白26抗体
xy-7357R TOM20线粒体外膜受体Tom20抗体
xy-13770R TWEAK肿瘤坏死因子配体超家族成员12抗体
xy-13803R THEG4/C1orf223睾丸高表达蛋白4抗体
xy-2789R Tap1ATP结合转运因子1抗体
xy-10155R Tetanus toxin light chain破伤风毒素轻链抗体
xy-2670R Tubb3/Tubulin beta 3微管蛋白β3抗体
xy-2773R TNFRSF13B肿瘤坏死因子受体超家族成员13B抗体
xy-3838R TXNDC4内质网蛋白44抗体
xy-2172R URG4 (C terminal)上调基因4抗体(C端)
xy-2786R Urocortin 3尿皮质素UCN3抗体
xy-2189R Uromucoid尿调节蛋白抗体
xy-9733R UFD1L泛素融合降解样蛋白1抗体
xy-9266R USP9X泛素特异性蛋白酶9X抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2 H1 :π1 ≠π2 α=0.05 2.计算理论数:(已完成列入四格表括弧中) 3.计算x2 值:应用公式(20.15)运算如下: 查x2 界值表,x2 0.05(1) =3.84,故x2 <x2 0.05(1) ,P>0.05. 按α=0.05水准,接受H0 ,两种疗效差异无统计学意义。 如果不采用校正公式,而用原基本公式,算得的结果x2 =4.068,则结论就不同
人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
X性联无丙种球蛋白血症(X-linked agammagl,bulinemia,XLA)是临床上首次确定的体液免疫缺陷病,由Brutor于1952年报道,故又称Bruton病。XLA作为常见的原发性免疫缺陷病之一,特点为血清中各类免疫球蛋白缺乏,或只能测得微量的抗体。外周血和淋巴组织中B细胞减少或完全缺乏,淋巴结中无生发中心和浆细胞。本病起病早,在出生数月后当患儿体内的母源性抗体水平下降时开始发病。临床表现为反复化脓性感染,患者细胞免疫功能不受影响(部分患者有T细胞数量减少),主要缺陷
技术资料暂无技术资料 索取技术资料





